Literature DB >> 8554605

Identification of an orphan receptor gene as a type 1 calcitonin gene-related peptide receptor.

S Kapas1, A J Clark.   

Abstract

Calcitonin gene-related peptide (CGRP) is a 37 residue neuropeptide that is distantly related to adrenomedullin. We have recently reported the cloning and expression of an adrenomedullin receptor which is approximately 30% homologous to the canine orphan receptor RDC-1. Therefore we tested the hypothesis that RDC-1 was a CGRP receptor. The RDC-1 gene was expressed in COS-7 cells and showed a dose dependant increase of cAMP in response to CGRP and adrenomedullin (EC50 values of 3 x 10(-9) M and 1 x 10(-7) M respectively) which was inhibited by the CGRP antagonist CGRP[8-37]. There was no cAMP response to amylin or [Cys(acm)2,7]a-hCGRP. Ligand binding studies confirmed high affinity of this receptor for CGRP and CGRP[8-37] with KD values of 9.2 x 10(-9) M and 13.4 x 10(-9) M respectively.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8554605     DOI: 10.1006/bbrc.1995.2847

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  18 in total

1.  CGRP and adrenomedullin binding correlates with transcript levels for calcitonin receptor-like receptor (CRLR) and receptor activity modifying proteins (RAMPs) in rat tissues.

Authors:  P Chakravarty; T P Suthar; H A Coppock; C G Nicholl; S R Bloom; S Legon; D M Smith
Journal:  Br J Pharmacol       Date:  2000-05       Impact factor: 8.739

2.  Adrenomedullin upregulates M2-muscarinic receptors in cardiomyocytes from P19 cell line.

Authors:  Sophie Buys; Fatima Smih; Atul Pathak; Pierre Philip-Couderc; Patrick Verwaerde; Jean-Louis Montastruc; Philippe Rouet; Jean-Michel Senard
Journal:  Br J Pharmacol       Date:  2003-07       Impact factor: 8.739

3.  Identification of a protein that confers calcitonin gene-related peptide responsiveness to oocytes by using a cystic fibrosis transmembrane conductance regulator assay.

Authors:  A E Luebke; G P Dahl; B A Roos; I M Dickerson
Journal:  Proc Natl Acad Sci U S A       Date:  1996-04-16       Impact factor: 11.205

Review 4.  Multisystem multitasking by CXCL12 and its receptors CXCR4 and ACKR3.

Authors:  Philip M Murphy; Lauren Heusinkveld
Journal:  Cytokine       Date:  2018-02-15       Impact factor: 3.861

5.  PTEN inhibits adrenomedullin expression and function in brain tumor cells.

Authors:  Simone A Betchen; Sergei Musatov; Jill Roberts; John Pena; Michael G Kaplitt
Journal:  J Neurooncol       Date:  2006-07-05       Impact factor: 4.130

Review 6.  Pituitary adenylate cyclase-activating polypeptide and islet amyloid polypeptide in primary sensory neurons: functional implications from plasticity in expression on nerve injury and inflammation.

Authors:  H Mulder; H Jongsma; Y Zhang; S Gebre-Medhin; F Sundler; N Danielsen
Journal:  Mol Neurobiol       Date:  1999-06       Impact factor: 5.590

Review 7.  Emerging roles of atypical chemokine receptor 3 (ACKR3) in normal development and physiology.

Authors:  K E Quinn; D I Mackie; K M Caron
Journal:  Cytokine       Date:  2018-09       Impact factor: 3.861

8.  Hydrops fetalis, cardiovascular defects, and embryonic lethality in mice lacking the calcitonin receptor-like receptor gene.

Authors:  Ryan T Dackor; Kimberly Fritz-Six; William P Dunworth; Carrie L Gibbons; Oliver Smithies; Kathleen M Caron
Journal:  Mol Cell Biol       Date:  2006-04       Impact factor: 4.272

9.  Comparison of the expression of calcitonin receptor-like receptor (CRLR) and receptor activity modifying proteins (RAMPs) with CGRP and adrenomedullin binding in cell lines.

Authors:  Tejal Choksi; Debbie L Hay; Stephen Legon; David R Poyner; Stefanie Hagner; Stephen R Bloom; David M Smith
Journal:  Br J Pharmacol       Date:  2002-07       Impact factor: 8.739

10.  Decoy receptor CXCR7 modulates adrenomedullin-mediated cardiac and lymphatic vascular development.

Authors:  Klara R Klein; Natalie O Karpinich; Scott T Espenschied; Helen H Willcockson; William P Dunworth; Samantha L Hoopes; Erich J Kushner; Victoria L Bautch; Kathleen M Caron
Journal:  Dev Cell       Date:  2014-09-08       Impact factor: 12.270

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.